Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Unicycive Therapeutics Inc UNCY

Healthcare Biotechnology
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb RZB 012 for the treatment of hyperphosphatemia in patients with chronic kidney... see more

Current News (NDAQ:UNCY)

Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Stockholders to Inquire about Securities Investigation

ACCESS Newswire 16 hours ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Investors to Learn More About the Investigation

ACCESS Newswire 3 days ago

Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire 5 days ago

Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire 7 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Stockholders to Learn More About the Investigation

ACCESS Newswire 10 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Investors to Inquire about Securities Investigation

ACCESS Newswire 12 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Investors to Reach Out

ACCESS Newswire January 4, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Reach Out

ACCESS Newswire January 1, 2026

Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)

GlobeNewswire December 29, 2025
View More News ››

Opinion & Analysis (NDAQ:UNCY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:UNCY)

Unicycive Therapeutics, Inc. (UNCY): Developing Novel Treatm

http://beyondspx.com/2024/08/02/unicycive-therapeutics-inc-uncy-developing-novel-treatments-for-kidney-disease/
MikeTester - August 3, 2024

UNCY....flirting with VWAP

Cheers !
Iseneschal - March 10, 2023

UNCY .... thru RBL at $2.63.... on watch still

it better get going.....Me no position
Iseneschal - March 10, 2023

UNCY.....now right in the "thick of res"....$2.50

N>H>O>D.......... All looks good...could go way higher.... I don't know ; ) I just want to say that.... Stops save...
Iseneschal - March 10, 2023

RE:UNCY .....The trend continues....Day 6 of run....Sheesh

I failed to mention that my chart tells me there congestion at this level.....resistance start at ~ $2.32 Cheers
Iseneschal - March 10, 2023

UNCY .....The trend continues....Day 6 of run....Sheesh

Close Prices Last 3 Months Price/volumes not adjusted for restructures Date Ex ...
Iseneschal - March 10, 2023
View more Bullboard ››

LaFleur Minerals Inc.

LaFleur Minerals Inc.

LaFleur Minerals Inc. explores for lithium and gold deposits in Canada. The company holds interest in the Swanson Gold ...
View More »

Podcasts